1Senterre JM,Carpentier M,Foidart JM.Vulvovaginal candidiasis:prevalence of different Candida species in the Liege region[J].Rev Med Liege,2005,60:882-884
2Fidel PL Jr.Immunity in vaginal candidiasis[J].Curr Opin Infect Dis,2005,18:107 -111
3Barousse MM,Steele C,Dunlap K,et al.Growth inhibition of Candida albicans by human vaginal epithelial cells[J].J Infect Dis,2001,184:1489-1493
4Steele C,Ozenci H,Fidel LW,et al.Growth inhibition of Candida albicans by vaginal cells from naive mice[J].Medical Mycology,1999,37:251-259
5Wozniak KL,Wormley FL Jr,Fidel PL Jr.Candida-Specific antibodies during experimental vaginal candidiasis in mice[J].Infect Immun,2002,70:5790-5799
6Cassone A,De Bernardis F,Torososantucci A.An outline of the role of anti-Candida antibodies within the context of passive immunization and protection from candidiasis[J].Curr Mol Med,2005,5:377-382
7Han Y,Morrison RP,Cutler JE.A Vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection[J].Infect Immun,1998,66:5771-5776
8Cutler JE.Defining criteria for anti-mannan antibodies to protect against candidiasis[J].Curr Mol Med,2005,5:383-392
9Cassone A,Boccanera M,Adriani D,et al.Rats clearing a vaginal infection by Candida albicans acquire specific,antibody-mediated resistance to vaginal reinfection[J].Infect Immun,1995,63:2619-2624